Microscopic colitis associated with lansoprazole: Report of two cases and a review of the literature

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 4, 2007, Pages 530-533

  Chande, Nilesh ^a,b   Driman, David K ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Collagenous colitis; Lansoprazole; Lymphocytic colitis; Microscopic colitis; Proton pump inhibitor

Indexed keywords

LANSOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

AGED; ARTICLE; CASE REPORT; COLLAGENOUS COLITIS; COLON BIOPSY; COLONOSCOPY; DIARRHEA; DRUG MECHANISM; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; GASTRITIS; GASTROESOPHAGEAL REFLUX; HUMAN; MICROSCOPIC COLITIS; PRIORITY JOURNAL; VERNER MORRISON SYNDROME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; COLITIS, MICROSCOPIC; FEMALE; HUMANS; PROTON PUMPS;

EID: 34147103977     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600997296     Document Type: Article

References (22)

1. Lazenby A, Yardly JH, Giardiello FM, Jessurun J, Bayless TM. Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 1989;20:18-28.
2. Giardiello FM, Lazenby AJ. The atypical colitides. Gastroenterol Clin North Am 1999;28:479-90.
3. Jessurun J, Yardley JH, Giardiello FM, Hamilton SR, Bayless TM. Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis). Histopathologic fndings in 15 patients. Hum Pathol 987;18:839-48.
4. Chande N, Driman DK, Reynolds RPE. Collagenous colitis and lymphocytic colitis: patient characteristics and clinical presentation. Scand J Gastroenterol 2005;40:343-7.
5. Fernandez-Banares F, Salas A, Forne M, Esteve M, Espinos J, Viver JM. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol 1999;92:418-23.
6. Agnarsdottir M, Gunnlaugsson O, Orvar KB, Cariglia N, Birgisson S, Bjornsson S, et al. Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci 2002;47:1122-228.
7. Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut 2004;53:536-41.
8. Fernandez-Banares F, Salas A, Esteve M, Espinos J, Forne M, Viver JM. Collagenous and lymphocytic colitis: evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol 2003;98:340-7.
9. Pardi DS, Smyrk TC, Tremaine WJ, Sandborn WJ. Microscopic colitis: a review. Am J Gastroenterol 2002;97:794-802.
10. Beaugerie L, Pardi DS. Review article: drug-induced microscopic colitis - proposal for a scoring system and review of the literature. Aliment Pharmacol Ther 2005;22:277-84.
11. Ghilain JM, Schapira M, Maisin JM, De Maeght S, Piron A, Gerard R, et al. Colite lymphocytaire associée à la prise de lansoprazole [Lymphocytic colitis associated with lansoprazole treatment]. Gastroenterol Clin Biol 2000;24:960-2.
12. Wilcox GM, Mattia A. Collagenous colitis associated with lansoprazole. J Clin Gastroenterol 2002;34:164-6.
13. Thomson RD, Lestina LS, Bensen SP, Toor A, Maheshwari Y, Ratcliffe NR. Lansoprazole-associated microscopic colitis: a case series. Am J Gastroenterol 2002;97:2908-13.
14. Mukherjee S. Diarrhea associated with lansoprazole. J Gastroenterol Hepatol 2003;18:602-3.
15. Rammer M, Kirchgatterer A, Hobling W, Knoflach P. Lansoprazole-associated collagenous colitis: a case report. Z Gastroenterol 2005;43:657-60.
16. Hilmer SN, Heap TR, Eckstein RP, Lauer CS, Shenfield GM. Microscopic colitis associated with exposure to lansoprazole. Med J Aust 2006;184:185-6.
17. Takahashi Y, Sakai H, Kuragari M, Suzuki T, Tauchi K, Minamimura T, et al. Expression of ATP1AL1, a non-gastric proton pump, in human colorectum. Jpn J Physiol 2002;52:317-21.
18. Binder HJ, Sangan P, Rajendran VM. Physiological and molecular studies of colonic H+, K+-ATPase. Semin Nephrol 1999;19:405-14.
19. Besancon M, Simon A, Sachs G, Shin JM. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents. J Biol Chem 1997;272:22438-46.
20. Martin RM, Dunn NR, Freemantle S, Shakir S. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies. Br J Clin Pharmacol 50:366-372.
21. Claessens AA, Heerdink ER, van Eijk JT, Lamers CB, Leufkens HG. Characteristics of diarrhea in 10,008 users of lansoprazole in daily practice: which co-factors contribute. Pharmacolepidemiol Drug Safety 2002;11:703-8.
22. Leufkens H, Claessens A, Heerdink E, vin Eijk J, Lamers CB. A prospective follow-up study of 5669 users of lansoprazole in daily practice. Aliment Pharmacol Ther 1997;11:887-97.